Modulari-T Biosciences

Modulus Therapeutics

This company develops engineered NK-cell therapies for autoimmune disease patients using a generative design and rapid prototyping platform.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

ArsenalBio

The company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.

Umoja Biopharma

This biotechnology company develops in vivo cell therapies to treat oncology and autoimmunity patients by generating chimeric antigen receptor T cells inside the body.

Autolus Therapeutics

This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.

Orca Bio

This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.

Arcellx

This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.

Mozart Therapeutics

The company develops CD8 T regulatory cell modulators to treat patients with autoimmune and inflammatory diseases including type 1 diabetes.